Unknown

Dataset Information

0

Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model.


ABSTRACT: Pancreatic cancer is one of the most aggressive cancers with a 5-year patient survival rate of 8.2% and limited availability of therapeutic agents to target metastatic disease. Pancreatic cancer is characterized by a dense stromal cell population with unknown contribution to the progression or suppression of tumor growth. In this study, we describe a microengineered tumor stromal assay of patient-derived pancreatic cancer cells to study the heterotypic interactions of patient pancreatic cancer cells with different types of stromal fibroblasts under basal and drug-treated conditions. The population dynamics of tumor cells in terms of migration and viability were visualized as a functional end point. Coculture with cancer-associated fibroblasts increased the migration of cancer cells when compared to dermal fibroblasts. Finally, we imaged the response of a bromodomain and extraterminal inhibitor on the viability of pancreatic cancer clusters surrounding by stroma in microengineered tumor stromal assay. We visualized a codynamic reduction in both cancer and stromal cells with bromodomain and extraterminal treatment compared to the dimethyl sulfoxide-treated group. This study demonstrates the ability to engineer tumor-stromal assays with patient-derived cells, study the role of diverse types of stromal cells on cancer progression, and precisely visualize a coculture during the screening of therapeutic compounds.

SUBMITTER: Mukundan S 

PROVIDER: S-EPMC6201185 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model.

Mukundan Shilpaa S   Sharma Kriti K   Honselmann Kim K   Singleton Amy A   Liss Andrew A   Parekkadan Biju B  

Technology in cancer research & treatment 20180101


Pancreatic cancer is one of the most aggressive cancers with a 5-year patient survival rate of 8.2% and limited availability of therapeutic agents to target metastatic disease. Pancreatic cancer is characterized by a dense stromal cell population with unknown contribution to the progression or suppression of tumor growth. In this study, we describe a microengineered tumor stromal assay of patient-derived pancreatic cancer cells to study the heterotypic interactions of patient pancreatic cancer c  ...[more]

Similar Datasets

| S-EPMC3632415 | biostudies-literature
| S-EPMC3782107 | biostudies-literature
| S-EPMC5870346 | biostudies-literature
| S-EPMC6671984 | biostudies-literature
| S-EPMC4991491 | biostudies-literature
| S-EPMC5245778 | biostudies-literature
2019-03-03 | GSE117548 | GEO
| S-EPMC8656238 | biostudies-literature
| S-EPMC4684431 | biostudies-literature
| S-EPMC6406729 | biostudies-literature